Latest filing published 21 Aug 2024 for Cytek Biosciences, Inc..
Insider track record
No signal scores available.
Paul Christopher Williams: trading record in brief
This profile gathers the share dealings of Paul Christopher Williams in Cytek Biosciences, Inc. Over a trading history stretching from 18 May 2023 to 19 August 2024, the count stands at 24 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 21 August 2024 came the latest disclosure, an option exercise in Cytek Biosciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Paul Christopher Williams
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,006 sharesCommon StockSEC:0001415889-24-021856:0
- 1,006 sharesCommon StockSEC:0001415889-24-014147:0
- 1,227 sharesCommon StockSEC:0001415889-24-007870:0
- 1,006 sharesCommon StockSEC:0001415889-24-004898:0
- 4,027 sharesCommon StockSEC:0001209191-23-056351:0
- 920 sharesCommon StockSEC:0001209191-23-046829:0
- 613 sharesCommon StockSEC:0001209191-23-031265:0
7 of 7 declarations
